Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 1
1(20.0%)
5Total
N/A(4)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02337881Phase 1Unknown

Management of Acute Preterm Labor: Nifedipen Alone or Combined With Cildenafil Citrate

Role: lead

NCT02522130Not ApplicableUnknown

Different Analgesics Prior to Intrauterine Device (IUD) Insertion: Is There Any Evidence?

Role: lead

NCT02345837Not ApplicableUnknown

Effect of Local Endometrial Injury on Pregnancy Outcomes During Ovulation Induction Cycles

Role: lead

NCT02362399Not ApplicableCompleted

Effect of Sildenafil Citrate on Uteri- Placental Perfusion, Doppler Indices in Growth Restricted Fetuses

Role: lead

NCT02372487Not ApplicableUnknown

Sildenafil Citrate Therapy for Oligohydramnios

Role: lead

All 5 trials loaded